Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan. [electronic resource] by
- Toft, Anders
- Urup, Thomas
- Christensen, Ib Jarle
- Michaelsen, Signe Regner
- Lukram, Babloo
- Grunnet, Kirsten
- Kosteljanetz, Michael
- Larsen, Vibeke Andrée
- Lassen, Ulrik
- Broholm, Helle
- Poulsen, Hans Skovgaard
Producer: 20180323
In:
Cancer investigation vol. 36
Availability: No items available.
|
|
15.
|
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients. [electronic resource] by
- Urup, Thomas
- Michaelsen, Signe Regner
- Olsen, Lars Rønn
- Toft, Anders
- Christensen, Ib Jarle
- Grunnet, Kirsten
- Winther, Ole
- Broholm, Helle
- Kosteljanetz, Michael
- Issazadeh-Navikas, Shohreh
- Poulsen, Hans Skovgaard
- Lassen, Ulrik
Producer: 20171031
In:
Molecular oncology vol. 10
Availability: No items available.
|
|
16.
|
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan. [electronic resource] by
- Urup, Thomas
- Dahlrot, Rikke Hedegaard
- Grunnet, Kirsten
- Christensen, Ib Jarle
- Michaelsen, Signe Regner
- Toft, Anders
- Larsen, Vibeke Andrée
- Broholm, Helle
- Kosteljanetz, Michael
- Hansen, Steinbjørn
- Poulsen, Hans Skovgaard
- Lassen, Ulrik
Producer: 20161213
In:
Acta oncologica (Stockholm, Sweden) vol. 55
Availability: No items available.
|
|
17.
|
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. [electronic resource] by
- Urup, Thomas
- Staunstrup, Line Mærsk
- Michaelsen, Signe Regner
- Vitting-Seerup, Kristoffer
- Bennedbæk, Marc
- Toft, Anders
- Olsen, Lars Rønn
- Jønson, Lars
- Issazadeh-Navikas, Shohreh
- Broholm, Helle
- Hamerlik, Petra
- Poulsen, Hans Skovgaard
- Lassen, Ulrik
Producer: 20170425
In:
BMC cancer vol. 17
Availability: No items available.
|